Levetiracetam in the treatment of epilepsy
Bassel Abou-KhalilDepartment of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee, USAAbstract: Epilepsy is a common chronic disorder that requires long-term antiepileptic drug therapy. Approximately one half of patients fail the initial antiepileptic drug and about 35% are refra...
Enregistré dans:
| Auteur principal: | Bassel Abou-Khalil |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2008
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/afbb07a100c54e9ba922ee64de489919 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Monotherapy for partial epilepsy: focus on levetiracetam
par: Antonio Gambardella, et autres
Publié: (2008) -
Changes in background electroencephalography and regional cerebral glucose metabolism in focal epilepsy patients after 1-month administration of levetiracetam
par: Kim SH, et autres
Publié: (2015) -
Levetiracetam as an alternative therapy for Tourette syndrome
par: MA Martínez-Granero, et autres
Publié: (2010) -
A meta-analysis of randomized controlled trials on levetiracetam in the treatment of pediatric patients with epilepsy
par: Zhang LL, et autres
Publié: (2018) -
Safety and efficacy of levetiracetam for the treatment of partial onset seizures in children from one month of age
par: Cormier J, et autres
Publié: (2013)